Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors

Details for Australian Patent Application No. 2007246889 (hide)

Owner Pulmagen Therapeutics (Inflammation) Limited

Inventors Finch, Harry; Ray, Nicholas Charles; Edwards, Christine; O'Connor, Elizabeth

Agent Griffith Hack

Pub. Number AU-B-2007246889

PCT Pub. Number WO2007/129060

Priority 0608844.7 04.05.06 GB; 0612544.7 23.06.06 GB

Filing date 3 May 2007

Wipo publication date 15 November 2007

Acceptance publication date 10 March 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

20 November 2008 PCT application entered the National Phase

  PCT publication WO2007/129060 Priority application(s): WO2007/129060

5 August 2010 Assignment before Grant

  Argenta Discovery Limited The application has been assigned to Pulmagen Therapeutics (Inflammation) Limited

10 March 2011 Application Accepted

  Published as AU-B-2007246889

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007246895-4- (2,6-dichloro-benzoylamino) - 1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) - amide for the treatment of cancer

2007246882-Methods of diagnosis and treatment of equine laminitis and Cushing' s syndrome